share_log

Zynex, Inc. (NASDAQ:ZYXI) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Zynex, Inc. (NASDAQ:ZYXI) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Zynex, Inc.(納斯達克股票代碼:ZYXI)第一季度業績剛剛公佈:以下是分析師對今年的預測
Simply Wall St ·  05/02 18:05

Investors in Zynex, Inc. (NASDAQ:ZYXI) had a good week, as its shares rose 4.8% to close at US$11.77 following the release of its first-quarter results. It was a curious result overall, with revenues coming in 2.4% below what the analysts had expected, at US$47m. The company broke even in terms of statutory earnings per share (EPS). Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

Zynex, Inc.(納斯達克股票代碼:ZYXI)的投資者度過了愉快的一週,在公佈第一季度業績後,其股價上漲了4.8%,收於11.77美元。總體而言,這是一個奇怪的結果,收入比分析師預期的4700萬美元低2.4%。該公司在法定每股收益(EPS)方面實現了收支平衡。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。我們認爲,讀者會發現分析師對明年最新(法定)業績後的預測很有趣。

earnings-and-revenue-growth
NasdaqGS:ZYXI Earnings and Revenue Growth May 2nd 2024
納斯達克股票代碼:ZYXI 收益和收入增長 2024 年 5 月 2 日

After the latest results, the five analysts covering Zynex are now predicting revenues of US$227.0m in 2024. If met, this would reflect a substantial 20% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to bounce 97% to US$0.51. Before this earnings report, the analysts had been forecasting revenues of US$227.4m and earnings per share (EPS) of US$0.48 in 2024. So the consensus seems to have become somewhat more optimistic on Zynex's earnings potential following these results.

根據最新業績,涵蓋Zynex的五位分析師現在預測2024年的收入爲2.27億美元。如果得到滿足,這將反映出與過去12個月相比收入大幅增長20%。預計每股法定收益將反彈97%,至0.51美元。在本業績發佈之前,分析師一直預測2024年的收入爲2.274億美元,每股收益(EPS)爲0.48美元。因此,在取得這些業績之後,人們對Zynex的盈利潛力的共識似乎變得更加樂觀了。

There's been no major changes to the consensus price target of US$18.98, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values Zynex at US$27.00 per share, while the most bearish prices it at US$15.00. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

18.98美元的共識目標股價沒有重大變化,這表明每股收益前景的改善不足以對股票估值產生長期的積極影響。研究分析師的估計範圍,評估異常值與平均值的差異也可能很有啓發性。目前,最看漲的分析師估值Zynex爲每股27.00美元,而最看跌的價格爲15.00美元。注意到分析師目標股價的巨大差距了嗎?對我們來說,這意味着基礎業務存在相當廣泛的可能情景。

Of course, another way to look at these forecasts is to place them into context against the industry itself. The period to the end of 2024 brings more of the same, according to the analysts, with revenue forecast to display 28% growth on an annualised basis. That is in line with its 32% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 8.1% annually. So it's pretty clear that Zynex is forecast to grow substantially faster than its industry.

當然,看待這些預測的另一種方法是將它們與行業本身聯繫起來。分析師表示,截至2024年底將帶來更多相同的情況,收入按年計算預計將增長28%。這與其在過去五年中32%的年增長率一致。相比之下,分析師估計(總計),整個行業的收入將每年增長8.1%。因此,很明顯,預計Zynex的增長速度將大大超過其行業。

The Bottom Line

底線

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Zynex's earnings potential next year. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

對我們來說,最大的收穫是共識的每股收益上調,這表明人們對Zynex明年盈利潛力的看法明顯改善。幸運的是,他們還再次確認了收入數字,表明收入符合預期。此外,我們的數據表明,收入的增長速度預計將快於整個行業。共識目標股價沒有實際變化,這表明該業務的內在價值與最新估計相比沒有發生任何重大變化。

With that in mind, we wouldn't be too quick to come to a conclusion on Zynex. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Zynex analysts - going out to 2026, and you can see them free on our platform here.

考慮到這一點,我們不會很快得出關於Zynex的結論。長期盈利能力比明年的利潤重要得多。根據多位Zynex分析師的估計,到2026年,你可以在我們的平台上免費查看。

And what about risks? Every company has them, and we've spotted 2 warning signs for Zynex you should know about.

那風險呢?每家公司都有它們,我們發現了兩個你應該知道的Zynex警告信號。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論